JVTNX | VEXRX | JVTNX / VEXRX | |
Total Expense Ratio | N/A | N/A | - |
Annual Report Gross Expense Ratio | N/A | N/A | - |
Fund Existence | 12 years | 23 years | - |
Gain YTD | 14.709 | 10.646 | 138% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 1000000 | 50000 | 2,000% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 3.25B | 22.6B | 14% |
Annual Yield % from dividends | 0.00 | 0.58 | - |
Returns for 1 year | 22.10 | 24.37 | 91% |
Returns for 3 years | -18.70 | -15.74 | 119% |
Returns for 5 years | 11.96 | 20.18 | 59% |
Returns for 10 years | 40.44 | 20.83 | 194% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
FIJYX | 37.59 | -0.06 | -0.16% |
Fidelity Advisor Biotechnology Z | |||
PLFIX | 28.11 | -0.06 | -0.21% |
Principal Large Cap S&P 500 Index Inst | |||
LSMIX | 13.53 | -0.04 | -0.29% |
Loomis Sayles Small/Mid Cap Growth Instl | |||
PZVIX | 12.38 | -0.09 | -0.72% |
Pzena International Small Cap Value Inv | |||
SCCVX | 13.98 | -0.20 | -1.41% |
AB Small Cap Value C |